“Ambercell Solutions” became part of the “Asker Healthcare Group” after the company was acquired by “OneMed.” This partnership will strengthen our ability to invest in integrated healthcare solutions and clinical supply chain automation, expand operations in the Baltic countries, and enter the broader European market.
The Ambercell Solutions team participated in the Terumo Interventional Systems Europe Distributor Summit 2026 and won the 2nd place award for growth in the field of interventional cardiology.
Surgeons and specialists of the operating teams of the Republican Šiauliai Hospital got acquainted with the Hugo™ RAS robotic surgery system and its application possibilities in modern minimally invasive surgery.
The Ambercell Solutions team participated in ECIO 2026, where the most important trends in interventional oncology emerged, from the development of ablation to multidisciplinary collaboration.
The first pulmonary cryoablation procedure was successfully performed at Tartu University Hospital. This move strengthens the development of interventional oncology services in the region and provides more minimally invasive treatment options for patients with lung tumors.
At Klaipėda University Hospital, a 70-year-old liver cancer patient who could not undergo surgery was given a minimally invasive treatment method – microwave ablation. During the procedure, the tumor is destroyed by precise exposure to heat, without damaging the surrounding tissues, and the patient’s recovery is faster and easier than after open surgery.